Crossmark

Identifying therapeutic target for prostate cancer: exploring Diosmetin as a CYP inhibitor

Published Online: 2024-12-20

Authors

Molla, Mohammad Habibur Rahman

Aljahdali, Mohammed Othman
Funding

Funding for this research was provided by:

King Abdulaziz University (527-130-2024)
License Information

Text and Data Mining valid from 2024-12-20

Version of Record valid from 2024-12-20
More Information

Article History

Received: 28 September 2024

Accepted: 16 December 2024

First Online: 20 December 2024

Declarations

:

: The authors declare no conflicts of interest.

: The authors declare no competing interests.

Document is current